introduction {#Introduction}
============

Ca^2+^ release channels (CRCs),^1^ also known as ryanodine receptors (RyRs), mediate the release of Ca^2+^ from an intracellular membrane compartment, the sarcoplasmic reticulum (SR), into the cytoplasm in striated muscle cells. The CRC has been purified as a 30 S protein complex and shown to be composed of four large RyR polypeptides of ∼5,000 amino acid residues and four immunophilins (FK506 binding protein) of ∼100 amino acid residues each. Three tissue-specific isoforms of RyR have been identified. The conductances and pharmacological properties of the three isoforms are, to a large extent, similar (for reviews, see [@B14]; [@B25]).

Traditionally, venom from many poisonous snakes, lizards, and scorpions has been a rich source of peptide toxins that target various voltage- and ligand-gated channels including the CRCs ([@B3]; [@B15], [@B16]). Recently, from the venom of the African scorpion *Pandinus imperator,* two factors, imperatoxin activator (IpTx~a~) and imperatoxin inhibitor (IpTx~i~), were isolated that selectively activated and inhibited, respectively, the CRCs ([@B31]; [@B2]). IpTx~a~ is a 33 amino acid peptide that activated the skeletal CRC in \[^3^H\]ryanodine binding and single channel studies. It did not exert a significant effect on cardiac CRC ([@B31]; [@B2]; [@B33]). IpTx~i~has been shown to be a heterodimeric protein (subunits of 108 and 27 amino acid residues covalently linked by a disulfide bond) with lipolytic action, and it inhibited both skeletal and cardiac CRCs by generating a lipid product ([@B31]; [@B34]).

Here, we show that IpTx~a~ induces voltage- and concentration-dependent subconductance states in both skeletal and cardiac CRCs when added to the cytosolic side. Analysis of voltage and concentration dependence and stochastic analysis of the events suggests that the induction of subconductance states corresponds to reversible, voltage-dependent binding and unbinding of IpTx~a~ at a single, cytosolically accessible site located in the voltage drop across the channel. IpTx~a~ also induced a subconductance state in the ryanodine-modified skeletal muscle CRC and affected \[^3^H\]ryanodine binding to skeletal and cardiac SR vesicles depending on the level of channel activation. These results provide evidence for the binding of IpTx~a~ to a channel site different from that of ryanodine.

materials and methods {#MaterialsMethods}
=====================

Phospholipids were obtained from Avanti Polar Lipids, Inc. (Alabaster, AL). All other chemicals were of analytical grade.

Preparation of SR Vesicles, and Purification and Reconstitution of Ca^2+^ Release Channels
------------------------------------------------------------------------------------------

SR vesicle fractions enriched in \[^3^H\]ryanodine binding and Ca^2+^ release channel activities were prepared in the presence of protease inhibitors from rabbit skeletal and canine cardiac muscle as described ([@B11]; [@B13]). The CHAPS (3-\[(3-cholamido-propyl)dimethylammonio\]-1-propanesulfonate)-solubilized skeletal or cardiac muscle 30 S Ca^2+^ release channel complex was purified and reconstituted into proteoliposomes by removal of CHAPS by dialysis ([@B7]).

Purification and Synthesis of IpTx~a~
-------------------------------------

IpTx~a~ was purified from *P. imperator* scorpion venom in three chromatographic steps as described ([@B31]; [@B2]; [@B33]). Synthetic IpTx~a~ was prepared as described ([@B33]).

Single Channel Measurements and Analysis
----------------------------------------

Single channel recordings of purified rabbit skeletal muscle or canine cardiac muscle CRCs incorporated into planar lipid bilayers were carried out as described ([@B29]; [@B32]). Preliminary experiments suggested that the rate of IpTx~a~-induced subconductance state formation depends on channel open probability (*P* ~o~) (see Fig. [4](#F4){ref-type="fig"} for a quantitative description). Therefore, experiments were conducted under "*P* ~o~-clamp" conditions with *P* ~o~ values kept in the range of 0.75--1.0. For the skeletal CRC, in most cases 1--2 mM ATP was added to the *cis* bilayer chamber that also contained ∼5 μM free Ca^2+^ to bring the *P* ~o~ in the required range. For the cardiac CRC, where no determination of the kinetic constants was attempted, one set of experiments was conducted using cytosolic contaminant Ca^2+^ (∼4 μM) (*P* ~o~= 0.3--0.5). In a second set, conducted under optimally activating conditions (10 μM cytosolic Ca^2+^), the *P* ~o~ was in the range of 0.8--1. Channel activities were recorded and analyzed using commercially available instruments and a software package (Axopatch 1D, Digidata 1200, and "pClamp 6.0.3;" Axon Instruments, Burlingame, CA). Recordings were filtered at 2 or 4 kHz through an eight-pole low pass Bessel filter (Frequency Devices Inc., Haverhill, MA) and digitized at 10 or 20 kHz. The current values for the full and subconductance states at different holding potentials were obtained by constructing all point amplitude histograms and subsequent Gaussian fits of data from at least 2 min of channel recording. The probability of substate occurrence (*P* ~substate~) was calculated as time spent in substate divided by the total recording time. Another parameter CRC~substate~/CRC~full\ state~ was calculated as time spent in substate divided by the time in full conductance state. The durations of the bursts (when the channel was in normal gating mode between the closed and full conductance levels) and subconductance states were obtained by manual positioning of the cursors.

\[^3^H\]Ryanodine Binding
-------------------------

\[^3^H\]Ryanodine binding experiments were carried out with rabbit skeletal and canine SR vesicles (protein: 150--250 μg/ml) in 0.25 M KCl, 20 mM imidazole, pH 7.0, 0.2 mM Pefabloc, 20 μM leupeptin, 0.1 mM EGTA, and \[CaCl~2~\] necessary to set the free \[Ca^2+^\] in the range of 0.1 μM to 10 mM. After incubation for 24 h at 24°C, bound radioactivity was determined by a filter assay as described ([@B29]). Nonspecific binding was determined with a 1,000-fold excess of unlabeled ryanodine.

Other Data Analysis and Conventions
-----------------------------------

Results are given as means ± SD with the number of experiments in parentheses. The SD is included within the figure symbol or indicated by error bars if it is larger. Significance of differences was analyzed with Student\'s paired *t* test. Differences were considered to be significant when *P* \< 0.05.

results {#Results}
=======

IpTx~a~ Induces Subconductance States in Skeletal and Cardiac Muscle CRCs
-------------------------------------------------------------------------

The skeletal and cardiac CRCs have been shown to conduct monovalent ions more efficiently than Ca^2+^ and to be essentially impermeant to Cl^−^. In 250 mM KCl solution, the single channel conductances of both isoforms are ∼770 pS ([@B14]; and this study). When 15 nM native IpTx~a~ was added to the cytosolic side (*cis* bilayer chamber) of a single skeletal CRC, the channel frequently entered a subconductance state (Fig. [1](#F1){ref-type="fig"} *A*, *left* and *right*). In contrast to the linear current--voltage relationship of the unmodified CRC, the IpTx~a~-modified channel showed a slightly rectifying behavior (Fig. [1](#F1){ref-type="fig"} *B*). The chord conductance at −40 mV holding potential was 344 ± 37 pS (∼43% of the full conductance state) and that at +40 mV was 221 ± 17 pS (∼28% of the full conductance state) (*n* = 8). Addition of up to 100 nM IpTx~a~ to the lumenal side (*trans* bilayer chamber) had no effect (data not shown). This suggested that IpTx~a~ induced subconductance states by interacting with the channel at a site accessible from the cytosolic side of the skeletal CRC. Occasionally, the CRC entered into conductance levels smaller than the main subconductance state. However, because of their very infrequent occurrences, these were not analyzed.

Fig. [2](#F2){ref-type="fig"} shows similar experiments carried out with the cardiac CRC. Cytosolic addition of 15 nM IpTx~a~ induced a substate (Fig. [2](#F2){ref-type="fig"} *A*) with a magnitude and rectifying current--voltage relationship (Fig. [2](#F2){ref-type="fig"} *B*) very similar to that of skeletal CRC. As was the case with skeletal CRC, addition of IpTx~a~ to the lumenal side of cardiac CRC was without effect.

With symmetrical 250 mM KCl and lumenal 25 mM Ca^2+^, the current carrier through the CRC is mostly Ca^2+^ at a holding potential of 0 mV. Under such recording conditions, IpTx~a~-induced subconductance states were observed for both the skeletal and cardiac muscle CRCs (data not shown). The substate conductances were ∼30% of the control full conductance values in both cases. Thus, induction of subconductance states in the CRCs by IpTx~a~ does not depend upon the current carrier species. From hereon, we shall describe experiments carried out on the skeletal CRC. Channel conductances and IpTx~a~ binding constants (see below) of the cardiac CRC are summarized and compared with the skeletal CRC in Table [I](#TI){ref-type="table"}.

Voltage, Concentration, and P~o~ Dependence of IpTx~a~-induced Substates
------------------------------------------------------------------------

The appearance of IpTx~a~-induced substates was highly voltage dependent. The probability of substate occurrence (*P* ~substate~) was ∼0.05 at a holding potential of −60 mV. As the holding potential was made less negative, *P* ~substate~ increased and reached a value close to 1 at positive holding potentials (40--60 mV) (data not shown).

The concentration dependence of IpTx~a~ effects on skeletal CRC was investigated at a holding potential of −20 mV by adding increasing concentrations of native IpTx~a~(from 6 to 100 nM) to the *cis* bilayer chamber. As shown in Fig. [3](#F3){ref-type="fig"}, *P* ~substate~ reached a value of 0.8 and greater as IpTx~a~ concentration was raised to 100 nM. A Lineweaver-Burk plot (Fig. [3](#F3){ref-type="fig"}, *inset*) indicated that the data could be described by Michaelis-Menten-type kinetics with a *P* ~substate,\ max~ close to 1 and a *K* ~m~ of 20 nM. Under the same recording conditions, a lower *K* ~m~ value (∼2 nM) was observed when experiments were carried out on skeletal CRC using synthetic IpTx~a~(data not shown).

The rate of IpTx~a~-induced substate formation was dependent on channel open probability. Fig. [4](#F4){ref-type="fig"} examines this question quantitatively by displaying the rates of subconductance state appearance and disappearance (see next section for the determination of IpTx~a~ association and dissociation rates) as a function of *P* ~o~. The subconductance states were rarely observed when the channel was closed, and the rate of their appearance increased linearly with *P* ~o~. In contrast, IpTx~a~ dissociation rate from the CRC was independent of *P* ~o~.

A Kinetic Scheme of IpTx~a~ and CRC Interaction, and Testing Its Predictions
----------------------------------------------------------------------------

The concentration, voltage, and *P* ~o~ dependence of IpTx~a~ action suggested that IpTx~a~ binds to the open channel at a single site located in the voltage drop across the channel. Following published procedures ([@B24]; [@B17]; [@B26]), we modeled the interaction of IpTx~a~ with CRC according to Scheme [SI](#FSI){ref-type="fig"}.

In Scheme [SI](#FSI){ref-type="fig"}, *V* refers to voltage across the membrane, v~on~ (*V*) and k~on~(*V*) are the observed microscopic voltage-dependent association rate and rate constant of IpTx~a~ binding to the channel, respectively. The velocity of IpTx~a~dissociation from the subconductance state, v~off~(*V*) is a unimolecular microscopic rate constant, k~off~, and is also voltage dependent. Assuming a Boltzmann distribution between the full and subconductance states, we can write CRC~substate~/CRC~full\ state~= exp \[(*z*δ*FV* − *G* ~0~)/ *RT*\], where CRC~substate~/CRC~full\ state~ refers to time spent in the subconductance state divided by the time spent in the full conductance state of the CRC.

The explicit dependence of k~on~ and k~off~ on voltage can be expressed as follows: k~on~(*V*) = k~on~(0)exp(*z*δ~1~ *FV*/ *RT*), and k~off~(*V*) = k~off~(0)exp(−*z*δ~2~ *FV*/*RT*), where *z* is the valence of the blocking particle, δ (= δ~1~+ δ~2~) is the fractional electrical distance of the binding site from the reference state at the cytosolic side, δ~1~is the distance between the transition state and the reference state, and *R*, *T,* and *F* have their usual meanings.

Channel activities of skeletal CRC were recorded in the presence of two different concentrations (15 and 100 nM) of native and one concentration (15 nM) of synthetic IpTx~a~ at various holding potentials. Ln (CRC~substate~/ CRC~full\ state~) values from one experiment in each condition are plotted against holding potential in Fig. [5](#F5){ref-type="fig"}. As predicted, the data followed Boltzmann distribution. The mean *z*δ values at 15 and 100 nM native IpTx~a~ were 1.44 ± 0.28 (*n* = 4) and 1.42 ± 0.28 (*n* = 3), respectively. The mean *z*δ from two experiments at 15 nM synthetic IpTx~a~ was 1.66. When all the data were pooled, the mean *z*δ was 1.49 ± 0.25 (*n* = 9) (Table [I](#TI){ref-type="table"}).

The voltage dependence of k~on~ and k~off~ was investigated for the skeletal CRC at 100 nM native and 15 nM synthetic IpTx~a~ at holding potentials varying from −60 to −20 mV. Dwell times corresponding to the substate and the burst mode were calculated from single channel records containing 30--150 events for each state. Following the predictions of Scheme [SI](#FSI){ref-type="fig"}, the distribution of dwell times in each state followed a single exponential (Fig. [6](#F6){ref-type="fig"}).

Plots of the natural logarithms of k~on~ and k~off~(obtained from exponential fits of dwell-time data) from four experiments against the holding potential followed Boltzmann distribution (not shown). The mean *z*δ~1~ and *z*δ~2~from four experiments (two at 100 nM native and two at 15 nM synthetic IpTx~a~) were 0.48 ± 0.04 and 1.06 ± 0.21, respectively, with a mean *z*δ of 1.54 ± 0.21. This latter value is almost identical to the mean *z*δ value of 1.49 ± 0.25, which was obtained from the plots of the natural logarithms of CRC~substate~/CRC~full\ state~ vs. holding potential (Fig. [5](#F5){ref-type="fig"} and Table [I](#TI){ref-type="table"}). The data further show that the unbinding rate is twice as voltage dependent as the binding rate. The mean k~on~ increased e-fold per +53.3 (±5.6 mV, *n* = 4) of applied holding potential. The mean k~off~ and mean *K* ~d~ decreased e-fold per +24.7 (±4.9 mV, *n* = 4) and +17.4 (±2.3 mV, *n* = 4) of applied holding potential, respectively.

Next, we tested the predictions pertaining to the IpTx~a~ concentration dependence of v~on~ and v~off~(Fig. [7](#F7){ref-type="fig"}). Skeletal CRC channel activities were recorded at a holding potential of −20 mV at five different native IpTx~a~ concentrations varying from 6 to 100 nM. The regression lines drawn through the mean v~on~ and v~off~data points have coefficients of determination of 0.99 and 0.02, respectively, thus supporting the prediction that v~on~ is linearly dependent on IpTx~a~ concentration and v~off~ is independent of it. From the data, a k~on~ (v~on~/\[IpTx~a~\]) value of 1.7 × 10^7^ M^−1^ s^−1^ and a k~off~ value of 0.31 s^−1^ were obtained, which gave a *K* ~d~ (k~off~/k~on~) of 18.2 nM. This *K* ~d~ value is very close to the *K* ~m~ value of 20 nM that was obtained from the Michaelis-Menten analysis of *P* ~substate~ vs. native \[IpTx~a~\] curve under identical recording conditions (−20 mV holding potential and 250 mM KCl medium) (Fig. [3](#F3){ref-type="fig"} and Table [I](#TI){ref-type="table"}).

IpTx~a~ Modifies \[^3^H\]Ryanodine Binding to Skeletal and Cardiac SR Vesicles
------------------------------------------------------------------------------

Previous studies had suggested that IpTx~a~ preferentially binds to and activates the skeletal CRC and that cardiac CRC is a poor target of IpTx~a~ ([@B31]; [@B2]; [@B33]). Since we observed that IpTx~a~ induces subconductance states in both the skeletal and cardiac CRCs, we reexamined the effects of IpTx~a~ in \[^3^H\]ryanodine binding experiments using skeletal and cardiac SR vesicles. Fig. [8](#F8){ref-type="fig"} shows the Ca^2+^ activation profiles of CRCs as measured by \[^3^H\]ryanodine binding to skeletal and cardiac SR vesicles in the absence and presence of 30 nM synthetic IpTx~a~. As observed previously ([@B31]; [@B2]; [@B33]), IpTx~a~ increased \[^3^H\]ryanodine binding to skeletal SR vesicles. Activation occurred at all tested Ca^2+^ concentrations with the possible exception of 10 mM, where \[^3^H\]ryanodine binding levels were close to background. In contrast to its effect on skeletal SR vesicles, IpTx~a~ decreased \[^3^H\]ryanodine binding to the cardiac SR vesicles up to twofold at a Ca^2+^ concentration of 10 μM--1 mM. At low (\<1 μM) and high (\>1 mM) Ca^2+^ concentration, it was without a noticeable effect.

\[^3^H\]ryanodine binding measurements have been and are extensively used as indicators of the number of channels and their activities ([@B14]). We did not observe an increase in *P* ~o~ of the skeletal CRC nor a decrease in *P* ~o~ of cardiac CRC in bilayer experiments after addition of IpTx~a~ (data not shown). Therefore, we were surprised to find that IpTx~a~ affected the \[^3^H\]ryanodine binding to skeletal and cardiac CRCs so differently. To gain further insights, we performed Scatchard analysis of \[^3^H\]ryanodine binding to both CRC isoforms in the presence and absence of IpTx~a~ (data not shown). IpTx~a~(30 nM, synthetic) decreased the *K* ~d~ of \[^3^H\]ryanodine binding to skeletal SR vesicles approximately threefold (Table [II](#TII){ref-type="table"}). A small increase in maximum binding (B~max~) (from 13.5 to 17.5 pmol/mg) was also observed after IpTx~a~ treatment. In contrast, 30 nM IpTx~a~ increased the *K* ~d~ of \[^3^H\]ryanodine binding to cardiac SR ∼3.5-fold without an appreciable effect on the B~max~ value. The above experiments were carried out at 100 μM free Ca^2+^. The cardiac CRC is nearly fully active at this \[Ca^2+^\] ([@B32]), whereas in the absence of other activating ligands, 100 μM Ca^2+^ cannot fully activate the skeletal CRC. To test if the different effects of IpTx~a~ on skeletal and cardiac SR vesicles were due to the different activation levels of CRCs, we performed Scatchard analysis of \[^3^H\]ryanodine binding using maximally activating conditions (100 μM Ca^2+^ and 5 mM AMP-PCP) for both CRC isoforms. Under these conditions, IpTx~a~ affected the \[^3^H\]ryanodine binding to the skeletal and cardiac SR vesicles in a similar manner. The *K* ~d~ of \[^3^H\]ryanodine binding to the skeletal SR vesicles increased ∼1.3-fold and that for the cardiac SR vesicles ∼4.5-fold without a change in the B~max~ values in both cases (Table [II](#TII){ref-type="table"}).

IpTx~a~ Induces Substates in Ryanodine-modified Skeletal Muscle CRC
-------------------------------------------------------------------

In Fig. [9](#F9){ref-type="fig"}, we explored the cointeraction of IpTx~a~ and ryanodine with the skeletal CRC at the single channel level. After addition of 100 nM IpTx~a~ to the *cis* bilayer chamber, the channel current fluctuated between the full conductance and IpTx~a~-induced subconductance states (Fig. [9](#F9){ref-type="fig"} *A*, *top*). After further addition of 5 μM ryanodine to the *cis* chamber, the channel current fluctuated between two new levels (Fig. [9](#F9){ref-type="fig"} *A, bottom*). The current--voltage relationships in presence of both IpTx~a~ and ryanodine are shown in Fig. [9](#F9){ref-type="fig"} *B*. The higher subconductance state had linear current--voltage characteristics and was identified as the ryanodine-modified subconductance state of the CRC ([@B6]). The less conducting IpTx~a~-induced substate of the ryanodine-modified CRC had a rectifying current--voltage characteristic. For comparison, the control and the IpTx~a~-induced substate current--voltage curves (in the absence of ryanodine) from Fig. [1](#F1){ref-type="fig"} *B* are redrawn as a dashed and dotted line, respectively, in Fig. [9](#F9){ref-type="fig"} *B*. The new substate conductance in the presence of both IpTx~a~ and ryanodine was significantly smaller than the IpTx~a~-induced substate (in the absence of ryanodine) at all applied holding potentials.

discussion {#Discussion}
==========

The present studies explored the effects of IpTx~a~ on purified CRCs in single channel experiments, and on SR vesicles in \[^3^H\]ryanodine binding experiments. In these studies, we provide the first evidence that IpTx~a~ directly interacts with both skeletal and cardiac CRCs to induce voltage- and concentration-dependent subconductance states in both isoforms by binding at a single site, located in the voltage drop across the channel. Second, we show that IpTx~a~ affects the \[^3^H\]ryanodine binding characteristics of the two isoforms depending on the level of channel activation.

Interaction of IpTx~a~ with CRCs as Revealed by Single-Channel Experiments
--------------------------------------------------------------------------

We modeled the interaction of IpTx~a~ with the CRC as outlined in Scheme [SI](#FSI){ref-type="fig"}. Briefly, we envisaged that when the channel opened, an IpTx~a~ molecule entered the conductance pathway from the cytosolic side to bind at an internal site. The model presented us with some testable predictions that were all satisfied. The distribution of dwell-times in each state (burst and subconductance) followed a single exponential. The reciprocal mean dwell-time in the burst state was linearly dependent on, and the reciprocal mean dwell-time in the subconductance state was independent of, IpTx~a~ concentration. A *K* ~d~ value of IpTx~a~ binding to skeletal CRC could be calculated from the dwell-time analysis, and it was very close to that obtained from the Michaelis-Menten-type concentration-dependence curve under identical conditions.

The effective valence of the reaction leading to substate formation was determined to be ∼1.5 for the skeletal CRC (the value for cardiac CRC was ∼1.3). From the known amino acid sequence of IpTx~a~ ([@B33]) and using the program "Isoelectric" of the GCG suite (Genetics Computer Group, Inc., Madison, WI), we calculated a net charge of 6.5 at pH 7.3. Dividing the effective valence by this number gives an electrical distance of ∼0.23 from the cytosolic side for the location of IpTx~a~ binding site. This is based on the assumption that all the charges of IpTx~a~ enter the CRC conduction pathway. The unbinding reaction of IpTx~a~ from the CRC has a twofold higher voltage dependence than the binding reaction. Higher voltage dependence for the unbinding rate has also been observed in case of tetrabutyl ammonium (TBA^+^)--induced substate in the cardiac CRC ([@B26]) and curare-induced subconductance state in the acetylcholine receptor channel ([@B24]).

IpTx~a~ is a relatively small peptide of 3,765 D with three pairs of cysteine residues that would stabilize the three-dimensional (3-D) conformation and help it assume a compact globular form by forming disulfide bridges ([@B33]). Preliminary modeling work suggests that IpTx~a~ structure can be roughly approximated as a sphere of ∼2.5 nm in diameter. The selectivity filter of the skeletal CRC has a diameter of ∼0.7 nm, as choline^+^, Tris^+^, and glucose can permeate through the channel ([@B12]; [@B23]), while sucrose cannot (G. Meissner, unpublished observations). Therefore, IpTx~a~ cannot enter the selectivity filter of the CRC. On the other hand, studies with large tetraalkyl ammonium ions ([@B26]) and charged local anesthetics ([@B28]) have suggested that the sheep cardiac CRC has a relatively large vestibule facing the cytosolic side. Theoretical considerations have suggested that a significant proportion of the voltage drop may fall over the wide vestibule of a channel ([@B5]). Our studies showed that the vestibule has to be at least 2--2.5-nm wide to accommodate IpTx~a~, and at least ∼23% of the voltage falls over the vestibule. Interestingly, 3-D cryo-electron micrographic reconstruction of the skeletal muscle CRC ([@B20]; [@B21]) shows a central opening of ∼5 nm in the cytoplasmic domain (facing the transverse tubule), and thus supports the presence of a wide vestibule facing the cytoplasmic side of the CRC.

Mechanism of Subconductance State Formation
-------------------------------------------

We considered it unlikely that IpTx~a~ would produce subconductance states by a surface charge mechanism ([@B4]). The estimated decrease in local \[K^+^\] using the Guoy-Chapman double-layer theory ([@B10]) was only approximately fourfold (assuming zero net surface charge near the cytosolic face of the CRC and the IpTx~a~ net positive charge of 6.5 spread out over a sphere of ∼2.5-nm diameter). This decrease (from 250 to 62.5 mM) was not sufficient to cause the subconductance state as the *K* ~d~ of K^+^ for the cardiac CRC has been shown to be ∼20 mM ([@B27]). However, if the positive charges of IpTx~a~ are clustered in a much smaller area (leading to a higher charge density), the local \[K^+^\] could be much lower, which may explain the formation of subconductance state. The above possibility is also not very likely as the ratios of subconductance to full conductance values were similar, and there was no indication of any relief of block, when the \[KCl\] in the bilayer chambers was increased symmetrically from 250 to 500 mM (data not shown). However, we observed an increase in the *K* ~d~ of IpTx~a~ binding to CRC when \[KCl\] was raised from 250 to 500 mM (our unpublished studies). Similar effects of increasing \[KCl\] on *K* ~d~ have been observed by other investigators studying other toxins ([@B1]; [@B8]).

In our experiments with the purified CRCs in bilayer experiments, substates of different amplitudes are sometimes observed even in control recordings. These substates show linear current--voltage relationships. Therefore, it is conceivable that IpTx~a~ preferentially binds to and stabilizes a normally occurring CRC substate. However, we think this to be an unlikely mechanism as the IpTx~a~-induced substates had different conductances at positive and negative holding potentials (Figs. [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}, and Table [I](#TI){ref-type="table"}).

How then does IpTx~a~ reduce channel conductance? Is it by partial occlusion of the channel pore or by a conformational change? Tetrabutyl and tetrapentyl ammonium--induced substates in the cardiac CRC have been explained in terms of partial occlusion of the conduction pathway ([@B26]). Convincing arguments have been put forward in favor of partial block of acetylcholine receptor channel by curare ([@B24]) and complete block of a maxi Ca^2+^-activated K^+^ channel by charybdotoxin ([@B1]; [@B9]). In the former case, displacing curare from the agonist binding sites of acetylcholine receptor channel had no effect on the kinetics of subconductance state occurrence. In the latter case, enhancement of external toxin dissociation by internal K^+^ and competition for the toxin-binding site by external tetraethylammonium ions gave strong support to the occlusion model. On the other hand, Zn^2+^-induced substates in canine cardiac sarcolemma sodium channel ([@B22]) and proton and deuterium ion-induced substates in a voltage-dependent Ca^2+^ channel ([@B19]; [@B18]) have been explained in terms of conformational changes; as in the above two cases, v~off~ was dependent on the blocker concentration. Furthermore, in case of dendrotoxin-I (DTX-I)-induced substate formation in a maxi Ca^2+^-activated K^+^ channel, a conformational change mechanism was also favored as the toxin converted the linear control current--voltage relationship to a rectifying one, though in this case v~on~ and v~off~ were linearly dependent on and independent of the toxin concentration ([@B8]). In the present case, IpTx~a~ binding converted an ohmic CRC to a rectifying one. Furthermore, IpTx~a~-modified CRCs (both skeletal and cardiac) had higher *K* ~d~s of \[^3^H\]ryanodine binding under fully activating conditions (conditions similar to bilayer recording conditions) (see below for further discussion on this aspect). These observations favor an IpTx~a~-induced conformational change in both the skeletal and cardiac CRCs as the mechanism causing the subconductance state. Alternatively, resultant conformational changes by the membrane electric field may cause IpTx~a~ to differentially occlude the CRC at positive and negative holding potentials to produce substates of different conductances. Regardless of whether partial occlusion of the pore or a conformational change is the mechanism causing subconductance state formation, our studies strongly suggest the existence of a cytosolically accessible IpTx~a~ binding site in the conductance pathway of both the skeletal and cardiac CRC.

Difference in Potency Between Native and Synthetic IpTx~a~
----------------------------------------------------------

Most of our experiments were conducted using native, purified IpTx~a~. In some experiments carried out using synthetic IpTx~a~, we observed that the synthetic toxin was ∼10-fold more effective in inducing substates in skeletal and cardiac CRCs than its native counterpart. The reasons for this difference are not clear. One possibility is that during purification the native toxin lost part of its biological activity.

Cointeraction of IpTx~a~ and Ryanodine with CRCs
------------------------------------------------

\[^3^H\]ryanodine binding correlates reasonably well with CRC activation levels. Because of its simplicity and convenience, it is extensively used to explore the effects of many drugs/toxins on CRC. But as this study shows, direct measurements of channel activity can provide insights that might not be detected by \[^3^H\]ryanodine binding measurements. When the effects of IpTx~a~ were assessed at 100 μM free Ca^2+^, an increase in \[^3^H\]ryanodine binding level for the skeletal but a decrease for the cardiac SR vesicles was observed (Fig. [8](#F8){ref-type="fig"}), though the net effect is the formation of subconductance states in both isoforms in bilayer experiments. Furthermore, using purified skeletal CRC, we demonstrated that IpTx~a~ can still bind and induce substates of slightly smaller conductances in the ryanodine-modified channel (Fig. [9](#F9){ref-type="fig"}, *A* and *B*). Similar paradoxical results were observed in studies exploring the effects of polyamines on the CRCs. Polyamines increased \[^3^H\]ryanodine binding to skeletal SR vesicles approximately fivefold ([@B35]). However, in single-channel studies, it caused a blockade of the cardiac CRC, and no increase in *P* ~o~ was observed ([@B30]). Though \[^3^H\]ryanodine binding and single channel experiments were done on different CRC isoforms, the above experiments and the present study call for caution in interpreting \[^3^H\]ryanodine binding results in the presence of other drugs and toxins.

The apparently paradoxical effects of IpTx~a~ on skeletal and cardiac SR vesicles in \[^3^H\]ryanodine binding measurements led us to investigate its effects in detail. At 100 μM Ca^2+^, IpTx~a~ caused a decrease in *K* ~d~ (with a small increase in B~max~) for the skeletal SR vesicles, but an increase in *K* ~d~ with little or no change in B~max~ for the cardiac SR vesicles (Table [II](#TII){ref-type="table"}). The affinity of \[^3^H\]ryanodine binding to SR vesicles correlates with the CRC activation level, suggesting that ryanodine binds to an open channel ([@B14]). The IpTx~a~-induced long-lived substates in the skeletal CRC would thus provide a favorable environment over the rapidly gating control low channel activity (at 100 μM Ca^2+^) for ryanodine entry into the CRC interior and subsequent binding. For the cardiac CRC, which is maximally active at 100 μM Ca^2+^, the substates provided no further improvement. On the contrary a decrease was observed, probably because the IpTx~a~-modified channel may have reduced affinity for ryanodine. In favor of this idea, we observed that under maximally activating conditions for both CRC isoforms (100 μM Ca^2+^ and 5 mM AMP-PCP), IpTx~a~ decreased the *K* ~d~s of \[^3^H\]ryanodine binding to both skeletal and cardiac SR vesicles (Table [II](#TII){ref-type="table"}). Furthermore, IpTx~a~ increased \[^3^H\]ryanodine binding to cardiac SR vesicles under minimally activating conditions (∼1 μM Ca^2+^) just as it increased \[^3^H\]ryanodine binding to skeletal SR vesicles under suboptimally activating conditions (100 μM Ca^2+^) (our unpublished studies). Thus, our data show that the IpTx~a~-modified CRC (both skeletal and cardiac) has a *K* ~d~ of \[^3^H\]ryanodine binding intermediate between those of the minimally and maximally activated channel.

In conclusion, the present work demonstrates a direct, high affinity interaction of IpTx~a~ with both the skeletal and cardiac CRCs. The use of IpTx~a~ should aid in the structural elucidation of the ion-conductance pathway of the skeletal and cardiac muscle CRCs. Furthermore, we show that experiments exploring effects of drugs/toxins on CRCs by \[^3^H\]ryanodine binding measurements must be interpreted with caution and be correlated with measurements of channel activity.
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CRC

:   Ca^2+^ release channel

IpTx~a~

:   imperatoxin activator

RyR

:   ryanodine receptor

SR

:   sarcoplasmic reticulum

![Dependence of v~on~ and v~off~ on the skeletal CRC open probability. The *P* ~o~ was varied by varying free Ca^2+^ in the *cis* bilayer chamber from \<0.1 to 20 μM and in some cases adding 1--2 mM ATP. 20 nM synthetic IpTx~a~ was added to the *cis* bilayer chamber and channel activities were recorded at a holding potential of −40 mV. The data are from three experiments. v~on~(○) and v~off~ (•) were obtained from exponential fits of dwell-times in the burst and subconductance state (see Fig. [6](#F6){ref-type="fig"}, legend). The coefficients of determination of the linear regression lines through the v~on~and v~off~data points were 0.98 and 0.17, respectively.](JGP7617.f4){#F4}

![Single exponential fits of dwell-time data. Data from an experiment with skeletal CRC at a holding potential of −20 mV and 100 nM cytosolic native IpTx~a~. (*A*) Exponential fit of dwell-times in the burst state. Data were sorted into histograms of 100-ms bin width in the cumulative binning mode and fitted to the probability distribution function *F*(*t*) = *A*(1 − exp\[−*t*/τ\]) (*solid line*), where total number of events (*A*) was 130 and the time-constant τ was 965 ms. (*B*) Exponential fit of dwell-times in the subconductance state. Data were sorted and fitted (*solid line*) as in *A*. The time-constant τ was 3,376 ms.](JGP7617.f6){#F6}

![IpTx~a~ induces a subconductance state in skeletal CRC. (*A*) Shown are four recordings from one experiment at the indicated holding potentials. Single channel currents, shown as downward or upward deflections from closed levels (*C*), were recorded in symmetrical 0.25 M KCl, 10 mM KHepes, pH 7.3. The *cis* solution also contained ∼5 μM free Ca^2+^ and 1 mM ATP. The top current traces were obtained under control conditions and the bottom traces after addition of 15 nM native IpTx~a~ to the *cis* solution. (*B*) Mean current values of the full conductance (○) and IpTx~a~-induced subconductance (•) states vs. holding potential. Data points are mean ± SD of eight experiments. The solid line through the full state current values is the linear regression line. The line through the substate current values was drawn by eye.](JGP7617.f1){#F1}

![IpTx~a~ induces a subconductance state in cardiac CRC. (*A*) Shown are four recordings from one experiment at indicated holding potentials. Single channel currents, shown as downward or upward deflections from closed levels (*C*), were recorded in symmetrical 0.25 M KCl, 20 mM KHepes, pH 7.4. The *cis* and *trans* chamber solutions contained contaminant-free Ca^2+^ (∼4 μM). The top recordings were obtained under control conditions and the bottom recordings after addition of 15 nM native IpTx~a~ to the *cis* solution. (*B*) Mean current values of the full conductance (○) and IpTx~a~-induced subconductance (•) states vs. holding potential. Data points are mean ± SD of three experiments. The solid line through the full state current values is the linear regression line. The line through the substate current values was drawn by eye.](JGP7617.f2){#F2}

###### 

Channel Conductances and IpTx~a~ Binding Constants of RyR1 and RyR2

                    RyR1             RyR2                                                                                                         
  -------------- -- ------------- -- ---------------------------------------------------------------------------------------- -- ------------- -- -------------------------------------------------------------------------------------
  g~−40~ (pS)       795 ± 26(8)         344 ± 37(8)                                                                              791 ± 11(3)      298[\*](#TFI-150){ref-type="table-fn"}
  g~+40~(pS)        795 ± 26(8)         221 ± 26(8)                                                                              791 ± 11(3)      187[\*](#TFI-150){ref-type="table-fn"}
  *K* ~m~ (nM)      ---              20(5)[‡](#TFI-152){ref-type="table-fn"}                                                     ---              6.7(1)[§](#TFI-153){ref-type="table-fn"}
  *K* ~d~ (nM)      ---              18.2(4)[‡](#TFI-152){ref-type="table-fn"}                                                   ---              ND
  *z*δ                               1.49 ± 0.25(9)[‖](#TFI-155){ref-type="table-fn"} [¶](#TFI-154){ref-type="table-fn"}                          1.32 ± 0.06(3)[‡](#TFI-152){ref-type="table-fn"} [¶](#TFI-154){ref-type="table-fn"}
  *z*δ                               1.54 ± 0.21(4)[‖](#TFI-155){ref-type="table-fn"} [\*\*](#TFI-160){ref-type="table-fn"}                       ND
  *z*δ~1~                            0.48 ± 0.04(4)[‖](#TFI-155){ref-type="table-fn"} [\*\*](#TFI-160){ref-type="table-fn"}                       ND
  *z*δ~2~                            1.06 ± 0.21(4)[‖](#TFI-155){ref-type="table-fn"} [\*\*](#TFI-160){ref-type="table-fn"}                       ND

The data are mean ± SD of the number of experiments given in parentheses.  

Estimated values at ±40 mV from the mean currents vs. voltage curve (Fig. [2](#F2){ref-type="fig"} B).  

and  

Obtained with native and synthetic IpTx~a~, respectively. The *K* ~m~ and *K* ~d~ values of native IpTx~a~ binding to skeletal CRC refer to values in 250 mM KCI medium and −20 mV holding potential. The *K* ~m~ of synthetic IpTx~a~ binding to the cardiac CRC was obtained in 250 mM KCI medium and at −25 mV holding potential.  

Mean values of experiments carried out with either native or synthetic IpTx~a~.  

Obtained from Boltzmann fit of CRC~substate~/CRC~full\ state~ vs. holding potential curves.  

Obtained from dwell-time analysis of bursts and substates. 

![Concentration dependence of IpTx~a~-induced substate. *P* ~substate~ vs. native \[IpTx~a~\] for the skeletal CRC. Channel activities were recorded as in Fig. [1](#F1){ref-type="fig"} *A* at a holding potential of −20 mV. Increasing concentrations (6--100 nM) of native IpTx~a~were added to the *cis* chamber solution. *P* ~substate~ was calculated at each \[IpTx~a~\]. Data points are mean ± SD of five experiments. A Lineweaver-Burk plot of the mean data is shown in the inset, giving a *K* ~m~ of 20 nM and a *P* ~substate,\ max~ of 0.91. Linear regression line drawn through the data points had a coefficient of determination of 0.97.](JGP7617.f3){#F3}

![](JGP7617.s1){#FSI}

![Plots of the natural logarithms of CRC~substate~/CRC~full\ state~ vs. holding potential for the skeletal CRC. Channel activities were recorded as in Fig. [1](#F1){ref-type="fig"} *A* at holding potentials of −60 to +60 mV. IpTx~a~ concentrations in the *cis* chamber solution were: 15 nM native (•), 100 nM native (○), and 15 nM synthetic (▴). The coefficients of determination and *z*δ values, respectively, were as follows: 15 nM native, 0.97 and 1.65; 100 nM native, 0.98 and 1.25; and 15 nM synthetic, 0.99 and 1.47.](JGP7617.f5){#F5}

![Dependence of v~on~ and v~off~ on \[IpTx~a~\]. Increasing concentrations (6--100 nM) of native IpTx~a~ were added to the *cis* solution and channel activities were recorded at −20 mV. The data are mean ± SD of three to four experiments except at 100 nM IpTx~a~, which is mean of two experiments. The coefficients of determination of the linear regression lines through the mean v~on~(○) and v~off~ (•) data points were 0.99 and 0.02, respectively.](JGP7617.f7){#F7}

![Effect of IpTx~a~ on \[^3^H\]ryanodine binding to SR vesicles. Specific \[^3^H\]ryanodine binding to rabbit skeletal (•, ▪) or canine cardiac (○, □) SR vesicles in the absence (•, ○) or presence (▪, □) of 30 nM synthetic IpTx~a~ was determined as described in [materials and methods]{.smallcaps}. The data are from one of three similar experiments with skeletal and cardiac SR vesicles.](JGP7617.f8){#F8}

###### 

\[^3^H\]Ryanodine Binding to Skeletal and Cardiac SR Vesicles

            Composition of assay media         B~max~ (pmol/mg protein)      *K* ~d~ (nM)                                                        
  ------ -- ------------------------------- -- -------------------------- -- ------------------------------------------------ -- ------------ -- -----------------------------------------------
  RyR1      100 μM Ca^2+^                      13.5 ± 0.9                    17.5 ± 2.1[\*](#TFII-150){ref-type="table-fn"}      16.6 ± 6.0      6.1 ± 2.7[\*](#TFII-150){ref-type="table-fn"}
            100 μM Ca^2+^ +  5 mM AMP PCP      17.5 ± 2.1                    16.2 ± 0.9                                           3.5 ± 1.4      4.7 ± 1.5[\*](#TFII-150){ref-type="table-fn"}
  RyR2      100 μM Ca^2+^                       3.5 ± 0.1                     3.9 ± 0.6                                           2.4 ± 0.8      8.4 ± 0.7[\*](#TFII-150){ref-type="table-fn"}
            100 μM Ca^2+^ +  5 mM AMP PCP       3.3 ± 0.4                     3.6 ± 0.2                                           1.8 ± 0.2      8.1 ± 1.0[\*](#TFII-150){ref-type="table-fn"}

The experiments were carried out using 30 nM synthetic IpTx~a~. The data are mean ± SD of three experiments.  

Significantly different from control conditions (−IpTx~a~). 

![Effects of IpTx~a~ and ryanodine on skeletal CRC. (*A*) IpTx~a~-induced subconductance states in the absence and presence of ryanodine. Shown are two current traces recorded at −40 mV. Single channel currents, shown as downward deflections from closed levels, were recorded in media as given in Fig. [1](#F1){ref-type="fig"} *A*, legend, but with 100 nM cytosolic native IpTx~a~. The top current trace was obtained before and the bottom trace after addition of 5 μM ryanodine to the *cis* solution. The current levels of the different states are indicated. (*B*) Current--voltage curves of skeletal CRC in presence of both IpTx~a~ and ryanodine. Channels were recorded as in *A*. The ryanodine- induced substate currents (○) and IpTx~a~-induced substate currents in the presence of ryanodine (•) are shown. The data are mean ± SD of three experiments. The dashed and dotted lines are the control and IpTx~a~-induced substate current-- voltage curves, respectively, in the absence of ryanodine, and are same as in Fig. [1](#F1){ref-type="fig"} *B*.](JGP7617.f9){#F9}
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